Microvascular thrombosis and multiple organ dysfunction syndrome.
about
Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartumAspirin as a potential treatment in sepsis or acute respiratory distress syndromeInflammation and haemostasisLocal hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shockClassifying types of disseminated intravascular coagulation: clinical and animal modelsProposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and HemostasisThe CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombiRenal complications of seasonal and pandemic influenza A virus infections.The role of the E2F1 transcription factor in the innate immune response to systemic LPS.Septic shock and chemotherapy-induced cytopenia: effects on microcirculation.The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulationA multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis.Effect of Red Blood Cells on Platelet Activation and Thrombus Formation in Tortuous ArteriolesBiology of sepsis: its relevance to pediatric nephrology.Urokinase-type plasminogen activator receptor as a predictor of poor outcome in patients with systemic inflammatory response syndromePhysiopathology of shockGlobal assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk.Optical Thromboelastography to evaluate whole blood coagulation.Sympathoadrenal activation and endothelial damage are inter correlated and predict increased mortality in patients resuscitated after out-of-hospital cardiac arrest. a post Hoc sub-study of patients from the TTM-trial.Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adultsIncreased prothrombotic property as a risk factor of acute kidney injury after surgical repair of abdominal aortic aneurysm: a prospective observational study.Association between aspirin therapy and the outcome in critically ill patients: a nested cohort studyEffect of Antiplatelet Therapy on Acute Respiratory Distress Syndrome and Mortality in Critically Ill Patients: A Meta-AnalysisInteractions between coagulation and complement--their role in inflammationImmunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 BalanceEvaluation of Presurgical Skin Preparation Agents in African Clawed Frogs (Xenopus laevis).Tortuosity triggers platelet activation and thrombus formation in microvesselsOutcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study.Using angiogenic factors and their soluble receptors to predict organ dysfunction in patients with disseminated intravascular coagulation associated with severe traumaRisk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study.Microvascular platforms for the study of platelet-vessel wall interactions.A conceptual and practical approach to haemostasis in paediatric liver disease.Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.Retrospective comparison of thromboelastography results to postmortem evidence of thrombosis in critically ill dogs: 39 cases (2005-2010).Design and Evaluation of New Unified Criteria for Disseminated Intravascular Coagulation Based on the Japanese Association for Acute Medicine Criteria.Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study.Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.Rationale for Adjunctive Therapies for Pediatric Sepsis Induced Multiple Organ Failure.Coagulofibrinolytic Changes in Patients with Post-cardiac Arrest Syndrome.Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis
P2860
Q24235909-B3D1E50D-3C7E-4C43-B174-76B6B958212EQ26780333-3E3FF6CC-5F3A-4742-A565-7AC6879FF058Q26823258-D537E26A-27A8-4929-92AE-AA4A2D406F77Q26861501-7A432832-E0C6-48C7-8AA3-81910218FF57Q27011864-F90C806C-EB7E-4D16-8DFF-DBEC28784F36Q28076449-124D52B6-B078-489C-B755-6E55C5AB1E05Q28513807-5EC9A351-65A6-49D9-BC79-DBF085FA5E20Q30422342-643A61BC-0AB7-465D-953F-7517D7656EA3Q30666153-A42B5364-488D-41D2-8EBB-BA82A46EEEC2Q33401213-F616677C-D524-46E7-93CD-49445A8EF558Q33751764-677B6C03-B9C5-42FE-B0A1-21E31BCF5DD4Q33752182-EDD7D311-AF76-48BD-949D-041B9CF66AF0Q33877964-E254B1F2-1FE0-4AC9-A42D-30D9561F3A4BQ33882451-A2FBF3AC-1867-4A64-8B19-1C5DDE6CD87AQ34032235-A2C1F400-B5E5-4633-B883-225A940B663EQ34631065-45929221-7798-42BC-A118-0A5D815ED514Q35025682-F5456C8C-48E3-4D16-8611-CD794547234CQ35139345-5CEDDB43-0481-49BA-BC8B-BC32D1B05EACQ35196597-C51FDFE0-9C6F-44CE-86B6-6A1CDFBD2203Q35559230-45C92174-5453-489C-B2C1-CD1084750F66Q35584637-1177F4F2-E23B-463E-8C68-372A3E2C6FD1Q35916354-4F797084-890B-43BC-B5DD-91E1DAD1CB1AQ36018451-6AAE2089-CE23-4264-AF77-8A6AD96D7E7CQ36022738-30082A91-A590-4691-8B07-79D7F981DBACQ36067334-BEFF541E-C7F1-4667-AF6F-648505298F23Q36352293-8FDACB1E-9F1F-489C-9D4E-451C4F284DDDQ36373837-6BA9B065-0DBE-477F-A1B7-76F4B4A3A553Q36663432-FB06C7AA-42F5-4E7F-B028-DA9119A3C064Q36925848-63975AEF-A03E-4037-AF4F-B86D439DE1ECQ37612236-D59FBC6B-1E61-4BEC-894B-D91B6CF5AFA3Q38179566-1E567D8C-5341-4E08-8067-6D1423AF3420Q38788396-7C7966F6-486C-4C58-BE15-CD0F564B114EQ39206078-14F39EBA-36AA-420A-BA8C-71C67F7175DEQ40125387-F35424DC-6FAA-4AA4-8F30-FF6474D7FDF7Q40838163-0D1753EB-4167-48CF-BC20-9113F211DC21Q41365182-4383BA70-0F2B-49E4-88E1-854F50401F0DQ41695234-3090415E-82EF-41A2-8E87-C5EF6FDB91E7Q41994903-40200A9F-36DC-4FDC-B642-99490FE2D51BQ42369766-A77C4BD1-584F-455B-BC4C-841510A65AD8Q42681372-20F3BD38-C4B8-4D7D-B824-18D4357AC79A
P2860
Microvascular thrombosis and multiple organ dysfunction syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Microvascular thrombosis and multiple organ dysfunction syndrome.
@ast
Microvascular thrombosis and multiple organ dysfunction syndrome.
@en
type
label
Microvascular thrombosis and multiple organ dysfunction syndrome.
@ast
Microvascular thrombosis and multiple organ dysfunction syndrome.
@en
prefLabel
Microvascular thrombosis and multiple organ dysfunction syndrome.
@ast
Microvascular thrombosis and multiple organ dysfunction syndrome.
@en
P1476
Microvascular thrombosis and multiple organ dysfunction syndrome.
@en
P2093
Satoshi Gando
P304
P356
10.1097/CCM.0B013E3181C9E31D
P407
P433
P577
2010-02-01T00:00:00Z